bromocriptine has been researched along with Pulmonary Fibrosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersohn, F; Garbe, E | 1 |
| Baran, AS; Rack, MJ; Richert, AC; Roffwarg, HP | 1 |
| Burger, E; Härtter, S; Kvernmo, T | 1 |
| Barat, M; Bellvert, P; Domblides, P; Douvier, JJ; Fréour, P; Taytard, A; Vergeret, J | 1 |
| Eberli, F; Greminger, P; Schmid, PA; Speich, R; Suter, T | 1 |
| Blomkvist, A; Hillerdal, G; Koyi, H; Lee, J; Rask-Andersen, A; Rasmussen, E; Uddenfeldt, M | 1 |
| De Vuyst, P; Gevenois, PA; Knoop, C; Lenclud, C; Mairesse, M | 1 |
| Debove, P; L'Her, P; Renard, JL; Simon, F; Vaylet, F | 1 |
| Genge, S; Hely, MA; Jeremy, R; Lawrence, S; Morris, JG | 1 |
| Edwards, RL; Oliver, WA; Todman, DH | 1 |
| Itoh, H; Kitagawa, M; Ooka, T; Watanabe, A | 1 |
| Kinnunen, E; Viljanen, A | 1 |
| Braunstein, GD; Melmed, S | 1 |
| Humby, MD; Thompson, J; Ward, CD | 1 |
| Skinner, C; Wiggins, J | 1 |
| Brottier, E; Domblides, P; Douvier, JJ; Dubos, F; Freour, P; Taytard, A; Vergeret, J | 1 |
2 review(s) available for bromocriptine and Pulmonary Fibrosis
| Article | Year |
|---|---|
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Heart Valve Diseases; Humans; Indoles; Pergolide; Pulmonary Fibrosis; Receptors, Dopamine | 2006 |
[Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Male; Parkinson Disease; Pleuropneumonia; Pulmonary Fibrosis; Tomography, X-Ray Computed | 1998 |
14 other study(ies) available for bromocriptine and Pulmonary Fibrosis
| Article | Year |
|---|---|
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States | 2009 |
Cardiopulmonary complications of ergot-derivative dopamine agonists.
Topics: Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia; Pergolide; Pulmonary Fibrosis; Risperidone | 2004 |
[Pleuropulmonary fibrosis and bromocriptine].
Topics: Bromocriptine; Humans; Male; Middle Aged; Pleura; Pleural Diseases; Pulmonary Fibrosis | 1984 |
[Bromocriptine-induced pleuropneumopathy].
Topics: Benserazide; Biperiden; Bromocriptine; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Pulmonary Atelectasis; Pulmonary Fibrosis; Radiography; Selegiline; Time Factors | 1994 |
Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Asbestos; Bromocriptine; Bronchoalveolar Lavage; Cohort Studies; Environmental Monitoring; Epidemiological Monitoring; Follow-Up Studies; Humans; Middle Aged; Occupational Exposure; Parkinson Disease; Pleural Diseases; Pulmonary Fibrosis; Radiography; Respiratory Function Tests; Risk Factors | 1997 |
Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?
Topics: Antiparkinson Agents; Asbestosis; Bromocriptine; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Humans; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Pleural Effusion; Pulmonary Fibrosis; Tomography, X-Ray Computed | 1997 |
Retroperitoneal fibrosis, skin and pleuropulmonary changes associated with bromocriptine therapy.
Topics: Bromocriptine; Female; Humans; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Skin Diseases | 1991 |
Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
Topics: Aged; Benserazide; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis; Serotonin | 1990 |
[A case of bromocriptine-induced interstitial pneumonitis in an iron factory worker exposed to sand dust].
Topics: Bromocriptine; Dust; Environmental Exposure; Humans; Iron; Male; Metallurgy; Middle Aged; Parkinson Disease; Pulmonary Fibrosis | 1989 |
[Bromocriptine and pulmonary responses].
Topics: Aged; Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Pulmonary Fibrosis; Radiography | 1989 |
Bromocriptine and pleuropulmonary disease.
Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis | 1989 |
Pleuropulmonary and retroperitoneal fibrosis associated with bromocriptine treatment.
Topics: Bromocriptine; Humans; Male; Middle Aged; Pulmonary Fibrosis; Retroperitoneal Fibrosis | 1987 |
Bromocriptine induced pleuropulmonary fibrosis.
Topics: Bromocriptine; Humans; Lung; Male; Middle Aged; Pleural Diseases; Pulmonary Fibrosis; Radiography | 1986 |
[Bromocriptine in Parkinson's disease: pleuropulmonary toxicity].
Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Pulmonary Fibrosis | 1985 |